Compare AJANTA PHARMA with Biocon - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs BIOCON - Comparison Results

BIOCON  
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA BIOCON AJANTA PHARMA/
BIOCON
 
P/E (TTM) x 24.7 32.6 75.9% View Chart
P/BV x 6.9 3.9 176.8% View Chart
Dividend Yield % 0.5 0.3 202.6%  

Financials

 AJANTA PHARMA   BIOCON
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
BIOCON
Mar-19
AJANTA PHARMA/
BIOCON
5-Yr Chart
Click to enlarge
High Rs1,422707 201.0%   
Low Rs898554 162.1%   
Sales per share (Unadj.) Rs233.591.9 254.1%  
Earnings per share (Unadj.) Rs44.016.7 263.1%  
Cash flow per share (Unadj.) Rs52.224.2 215.7%  
Dividends per share (Unadj.) Rs9.001.00 900.0%  
Dividend yield (eoy) %0.80.2 489.3%  
Book value per share (Unadj.) Rs255.1101.6 251.0%  
Shares outstanding (eoy) m88.02600.00 14.7%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x5.06.9 72.4%   
Avg P/E ratio x26.437.7 69.9%  
P/CF ratio (eoy) x22.226.1 85.3%  
Price / Book Value ratio x4.56.2 73.3%  
Dividend payout %20.56.0 342.1%   
Avg Mkt Cap Rs m102,081378,330 27.0%   
No. of employees `0006.86.1 110.9%   
Total wages/salary Rs m4,30711,653 37.0%   
Avg. sales/employee Rs Th3,022.68,994.3 33.6%   
Avg. wages/employee Rs Th633.41,900.7 33.3%   
Avg. net profit/employee Rs Th569.11,635.3 34.8%   
INCOME DATA
Net Sales Rs m20,55455,144 37.3%  
Other income Rs m2111,444 14.6%   
Total revenues Rs m20,76556,588 36.7%   
Gross profit Rs m5,66415,883 35.7%  
Depreciation Rs m7214,478 16.1%   
Interest Rs m12709 1.6%   
Profit before tax Rs m5,14312,140 42.4%   
Minority Interest Rs m09 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,2732,123 60.0%   
Profit after tax Rs m3,87010,026 38.6%  
Gross profit margin %27.628.8 95.7%  
Effective tax rate %24.817.5 141.5%   
Net profit margin %18.818.2 103.6%  
BALANCE SHEET DATA
Current assets Rs m11,81248,228 24.5%   
Current liabilities Rs m3,77630,376 12.4%   
Net working cap to sales %39.132.4 120.8%  
Current ratio x3.11.6 197.0%  
Inventory Days Days7768 113.3%  
Debtors Days Days8286 95.4%  
Net fixed assets Rs m14,39864,130 22.5%   
Share capital Rs m1753,000 5.8%   
"Free" reserves Rs m22,27757,980 38.4%   
Net worth Rs m22,45260,980 36.8%   
Long term debt Rs m715,766 0.0%   
Total assets Rs m26,962121,924 22.1%  
Interest coverage x444.318.1 2,451.8%   
Debt to equity ratio x00.3 0.1%  
Sales to assets ratio x0.80.5 168.6%   
Return on assets %14.48.8 163.5%  
Return on equity %17.216.4 104.8%  
Return on capital %23.016.8 137.0%  
Exports to sales %028.1 0.0%   
Imports to sales %018.9 0.0%   
Exports (fob) Rs mNA15,506 0.0%   
Imports (cif) Rs mNA10,399 0.0%   
Fx inflow Rs m10,68215,506 68.9%   
Fx outflow Rs m2,10210,399 20.2%   
Net fx Rs m8,5805,107 168.0%   
CASH FLOW
From Operations Rs m3,74811,546 32.5%  
From Investments Rs m-2,228-7,138 31.2%  
From Financial Activity Rs m-1,475-2,417 61.0%  
Net Cashflow Rs m452,103 2.1%  

Share Holding

Indian Promoters % 73.8 40.4 182.7%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 1.6 8.4 18.5%  
FIIs % 7.6 10.7 71.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 19.9 85.4%  
Shareholders   20,968 109,995 19.1%  
Pledged promoter(s) holding % 4.4 0.0 10,975.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   AUROBINDO PHARMA  ORCHID PHARMA  SANOFI INDIA  FULFORD INDIA  SHASUN PHARMA  

Compare AJANTA PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 441 Points Lower; Nifty Settles Below 15,000-Mark(Closing)

Indian share markets witnessed huge selling during closing hours today and ended their day lower.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

BIOCON Announces Quarterly Results (3QFY21); Net Profit Down 19.7% (Quarterly Result Update)

Jan 25, 2021 | Updated on Jan 25, 2021

For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

How Much Money For Day Trading?(Fast Profits Daily)

Feb 22, 2021

In this video, I'll show you how to allocate your capital as a day trader.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Mar 5, 2021 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 8-QTR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS